The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian Cancer.
Meshach Asare-WereheneRobert A HunterEmma GerberArkadiy ReunovIsaiah BrineChia-Yu ChangChia-Ching ChangDar-Bin ShiehDylan BurgerHanan AnisBenjamin K TsangPublished in: Cancers (2023)
These findings highlight pGSN as a potential therapeutic target and provide a potential diagnostic platform to detect OVCA earlier and predict chemoresistance; an intervention that will positively impact patient-survival outcomes.